Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury

被引:112
作者
Donkin, James J. [1 ]
Nimmo, Alan J. [1 ]
Cernak, Ibolja [2 ]
Blumbergs, Peter C. [3 ]
Vink, Robert [1 ,3 ]
机构
[1] Univ Adelaide, Discipline Pathol, Adelaide, SA 5005, Australia
[2] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA
[3] Hanson Inst Ctr Neurol Dis, Adelaide, SA, Australia
关键词
brain trauma; cerebral edema; neurogenic inflammation; neuropeptides; SPINAL-CORD ASTROCYTES; NEUROGENIC INFLAMMATION; MAGNESIUM-DEFICIENCY; TIME-COURSE; RECEPTOR; RATS; TACHYKININ; VASODILATATION; PATHOBIOLOGY; ANTAGONIST;
D O I
10.1038/jcbfm.2009.63
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Brain edema and swelling is a critical factor in the high mortality and morbidity associated with traumatic brain injury (TBI). Despite this, the mechanisms associated with its development are poorly understood and interventions have not changed in over 30 years. Although neuropeptides and neurogenic inflammation have been implicated in peripheral edema formation, their role in the development of central nervous system edema after brain trauma has not been investigated. This study examines the role of the neuropeptide, substance P (SP), in the development of edema and functional deficits after brain trauma in rats. After severe diffuse TBI in adult male rats, neuronal and perivascular SP immunoreactivity were increased markedly. Perivascular SP colocalized with exogenously administered Evans blue, supporting a role for SP in vascular permeability. Inhibition of SP action by administration of the neurokinin-1 (NK1) antagonist, N-acetyl-L-tryptophan, at 30 mins after trauma attenuated vascular permeability and edema formation. Administration of the NK1 antagonist also improved both motor and cognitive neurologic outcomes. These findings suggest that SP release is integrally linked to the increased vascular permeability and edema formation after brain trauma, and that treatment with an NK1 receptor antagonist reduces edema and improves neurologic outcome. Journal of Cerebral Blood Flow & Metabolism (2009) 29, 1388-1398; doi: 10.1038/jcbfm.2009.63; published online 13 May 2009
引用
收藏
页码:1388 / 1398
页数:11
相关论文
共 43 条
[1]   Diffusion and high resolution MRI of traumatic brain injury in rats: Time course and correlation with histology [J].
Albensi, BC ;
Knoblach, SM ;
Chew, BGM ;
O'Reilly, MP ;
Faden, AI ;
Pekar, JJ .
EXPERIMENTAL NEUROLOGY, 2000, 162 (01) :61-72
[2]   Time course of cerebral edema after traumatic brain injury in rats: Effects of riluzole and mannitol [J].
Bareyre, F ;
Wahl, F ;
McIntosh, TK ;
Stutzmann, JM .
JOURNAL OF NEUROTRAUMA, 1997, 14 (11) :839-849
[3]  
Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125
[4]   The pathobiology of moderate diffuse traumatic brain injury as identified using a new experimental model of injury in rats [J].
Cernak, I ;
Vink, R ;
Zapple, DN ;
Cruz, MI ;
Ahmed, F ;
Chang, T ;
Fricke, ST ;
Faden, AI .
NEUROBIOLOGY OF DISEASE, 2004, 17 (01) :29-43
[5]   Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection in vitro and in vivo [J].
Faden, AI ;
Knoblach, SM ;
Cernak, I ;
Fan, L ;
Vink, R ;
Araldi, GL ;
Fricke, ST ;
Roth, BL ;
Kozikowski, AP .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2003, 23 (03) :342-354
[6]   A NEW MODEL OF DIFFUSE BRAIN INJURY IN RATS .2. MORPHOLOGICAL CHARACTERIZATION [J].
FODA, MAA ;
MARMAROU, A .
JOURNAL OF NEUROSURGERY, 1994, 80 (02) :301-313
[7]   INTRATHECAL SOMATOSTATIN, SOMATOSTATIN ANALOGS, SUBSTANCE-P ANALOG AND DYNORPHIN-A CAUSE COMPARABLE NEUROTOXICITY IN RATS [J].
GAUMANN, DM ;
GRABOW, TS ;
YAKSH, TL ;
CASEY, SJ ;
RODRIGUEZ, M .
NEUROSCIENCE, 1990, 39 (03) :761-774
[8]  
HAFSTROM I, 1989, J RHEUMATOL, V16, P1033
[9]   Neurobehavioral assessment of outcome following traumatic brain injury in rats: An evaluation of selected measures [J].
Hamm, RJ .
JOURNAL OF NEUROTRAUMA, 2001, 18 (11) :1207-1216
[10]  
HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843